Interferon-alpha Lozenges for Prevention of Relapse in Hepatitis C
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether lozenges of interferon-alpha that are
dissolved in the mouth can prevent relapse in patients with hepatitis C virus infection who
had a complete virologic response after receiving a combination of injected interferon-alpha
and oral ribavirin.